http://www.biospace.comBioSpace RSS GeneratorTue, 21 May 2013 10:55:37 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.pharmalive.com/the-ranbaxy-whistleblower-and-the-scheme-to-fool-the-fdaStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Earlier this week, the feds finally reached closure with Ranbaxy Laboratories with a $500 million deal to settle criminal and civil charges for a serious and widespread manufacturing ruse. The generic drugmaker...Thu, 16 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/ranbaxy-pays-500m-to-settle-long-running-production-scandalStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>More than a year after entering into a consent decree over a far-reaching manufacturing scandal, Ranbaxy Laboratories has agreed to pay $500 million to settle criminal and civil charges associated with the episode...Tue, 14 May 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/05/14/us-sanofi-plavix-idUSBRE94D09V20130514Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>File this under 'Why didn't they know any better?' Four years ago, Sanofi grew worried that a generic version of its best-selling Plavix bloodthinner would gain attention from physicians and pharmacies in France...Tue, 14 May 2013 12:00:00 AM GMThttp://www.foxnews.com/world/2013/05/09/pfizer-executive-in-puerto-rico-faces-federal-charges-producing-child/Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Federal authorities in Puerto Rico have arrested an executive at Pfizer Pharmaceutical for allegedly producing child pornography. Officials say 48-year-old Reinaldo Diaz Camacho was charged after Puerto Rico...Mon, 13 May 2013 12:00:00 AM GMThttp://www.pharmalive.com/teva-regrets-firing-employee-who-developed-a-brain-tumorStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Teva Pharmaceuticals, one of the bulwarks of the Israeli economy, has decided not to fight a court ruling that, essentially, leaves the drugmaker looking insensitive heartless. A Tel Aviv District Labor Court...Tue, 07 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=295098&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br> DEERFIELD, Ill., May 1, 2013 -- /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-1...Thu, 02 May 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294841&full=130 April 2013 -- Commenting on the interim ruling of the General Court of the European Union preventing the European Medicines Agency (EMA) from providing documents as part of two access-to-documents requests until a final ruling is given by the Court, Steve Bates, BioIndustry Association (BIA) Chief Executive Officer, said:</p><p>"The interim ruling must not delay the timetable for introducing...Tue, 30 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294655&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>EAST HANOVER, N.J.</span>, <span class"xn-chron">April 26, 2013</span> /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) disputes the allegations made by the US Attorney's Office (USAO) for the...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294657&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>DEERFIELD, Ill.</span>, <span class"xn-chron">April 26, 2013</span> /PRNewswire/ -- Takeda Pharmaceuticals <span class"xn-location">U.S.A.</span>, Inc. announced today that in the case of <span class...Mon, 29 Apr 2013 12:00:00 AM GMThttp://www.winnipegsun.com/2013/04/18/winnipeg-based-canada-drugs-lays-off-hundreds-of-employees-worldwideStaying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>A salesman who marketed illegal cancer treatments in the U.S. for a Canadian company embroiled in a counterfeit-drug scandal is scheduled to plead guilty on Wednesday to a federal charge of covering up a...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.insidermedia.com/insider/north-west/89107-Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Global pharmaceutical giant AstraZeneca said today (25 April 2013) it was helping authorities in America with an investigation into its plant in Macclesfield. The drugs group's base in the Cheshire town is...Thu, 25 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=294212&full=1Staying up-to-date has never been simpler. Sign up for the <a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup">free GenePool newsletter</a> today!<br><br>Tuesday, April 23, 2013 -- Suit Alleges Novartis Induced Pharmacies to Switch Thousands of Transplant Patients to One of Its Drugs with Kickbacks Disguised as Rebates and Discounts, Resulting in Medicare...Wed, 24 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/16/bayer-yasmin-patent-idUSL2N0D31FN20130416Bayer AG (BAYN)s patent on the birth control pill Yaz is invalid, a U.S. appeals court said in a decision that ensures Actavis Inc. (ACT) and Novartis AG (NOVN)s Sandoz unit can sell copies of the contraceptive. Actavis, Sandoz and Lupin Ltd. (LPC) won a ruling that the patent is invalid because its an obvious variation of earlier know- how, the U.S. Court of Appeals for the Federal Circuit in Washington...Thu, 18 Apr 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-04-15/takeda-s-actos-diabetes-drug-tied-to-cancer-jury-is-told.htmlTakeda Pharmaceutical Co. (4502), Asias biggest drugmaker, hid the cancer risks of its Actos drug to protect billions in sales, a jury was told in the first of more than 3,000 lawsuits over the diabetes medication to go to trial. While Takedas internal Actos studies uncovered links to bladder cancer as early as 2004, the company didnt alert U.S. regulators until seven years later, Michael Miller...Tue, 16 Apr 2013 12:00:00 AM GMThttp://www.philly.com/philly/blogs/phillypharma/Supreme-Court-denies-Glaxo-appeal-allowing-Humana-to-sue-the-drugmaker---.htmlThe U.S. Supreme Court Monday denied a request by drugmaker GlaxoSmithKline to hear its appeal of a decision by U.S. Court of Appeals for the Third Circuit, which allowed health insurance giant Humana to sue Glaxo over sales of Glaxo's controversial diabetes drug Avandia. The Third Circuit is based in Philadelphia and the original suit was filed there. Glaxo also has a huge presence in the city and...Tue, 16 Apr 2013 12:00:00 AM GMThttp://zeenews.india.com/business/news/companies/drug-patent-row-hc-seeks-glenmarks-response-by-may-22_74055.htmlThe Delhi High Court on Friday sought response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme's appeal against the single judge bench order refusing to restrain the Indian firm from manufacturing and selling anti-diabetes drugs Zita and Zita-Met. A bench of Justices S Ravindra Bhat and S K Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging...Mon, 15 Apr 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-04-10/bayer-sues-fda-seeking-to-block-sales-of-generic-baytril.htmlBayer AG (BAYN) sued the U.S. Food and Drug Administration seeking to block sales of a generic form of the livestock antibiotic Baytril 100 being sold by competitor Norbrook Laboratories Ltd. Bayer, in a complaint filed today in Washington, said the FDAs approval of Norbrooks Enroflox 100 product to treat bovine respiratory disease was unlawful because the agency hadnt responded to Bayers concerns...Thu, 11 Apr 2013 12:00:00 AM GMThttp://www.indystar.com/article/20130409/BUSINESS/304090105/Eli-Lilly-Co-settles-wrongful-death-lawsuit?&gcheck=1Eli Lilly and Co. has settled a long-running wrongful death lawsuit filed by the parents of a South Dakota boy who committed suicide on Christmas Eve 2004, four weeks after taking the antidepressant Cymbalta. The settlement comes a month before a jury trial was set to begin in a South Dakota federal court. Terms werent disclosed in court filings. An order filed last week by a magistrate judge said...Wed, 10 Apr 2013 12:00:00 AM GMThttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/patent-row-delhi-high-court-refuses-interim-relief-to-us-drug-firm-merck/articleshow/19398921.cmsThe Delhi High Court today refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark PharmaceuticalsBSE -0.07 % on manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim application of the multinational pharma major that the Mumbai-based firm be...Fri, 05 Apr 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=292381&full=1April 04, 2013 -- Actavis Inc. (>> Actavis Inc) confirmed a New Jersey court has granted a motion from AstraZeneca PLC (>> AstraZeneca plc) seeking a temporary restraining order to prevent Actavis from further distributing its generic version of asthma treatment Pulmicort Respules.</p><p>The ruling follows the Monday launch of Actavis's product after the court found that Actavis's 0.25, 0.5 and...Thu, 04 Apr 2013 12:00:00 AM GMThttp://www.pharmatimes.com/Article/13-04-03/Merck_Co_sues_Glenmark_over_copycats_of_diabetes_drugs.aspxUS-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering yet another legal battle between an Indian generic company and a member of Big Pharma. MSD's move comes a week after Glenmark Pharma launched generic versions of a range of anti-diabetes products sold by...Wed, 03 Apr 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/04/01/us-india-novartis-patent-idUSBRE93002I20130401India's top court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics. The decision sets a benchmark for intellectual property cases in India, where many patented drugs are unaffordable for most of its 1.2 billion people, and does not...Mon, 01 Apr 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-03-26/novo-lures-sanofi-pitchman-as-diabetes-battle-heats-up.htmlAs a former professional cyclist, Phil Southerland knows about competition. So when Southerland, a diabetic whose team was funded by drugmaker Sanofi (SAN) for six years, wanted a better sponsorship deal, he knew who to contact: archrival Novo Nordisk A/S (NOVOB). Novo was quick to snap him up, offering a contract worth several million dollars, according to people familiar with the negotiations. The...Thu, 28 Mar 2013 12:00:00 AM GMThttp://www.pharmalot.com/2013/03/french-regulator-investigated-over-servier-scandal/The scandal over a Servier Laboratories diabetes pill, which has been blamed for at least 500 deaths in France, has now ensnared the French regulatory agency. The ANSM has come under formal investigation for alleged involuntary manslaughter over concerns the agency neglected to respond to numerous reports that the Mediator drug, which was withdrawn four years ago, was causing serious harm. The move...Fri, 22 Mar 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=291344&full=1<div id"releaseBody"><p>LYON, FRANCE--(Marketwire - March 22, 2013) - Flamel Technologies (NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerFLML">FLML</a>) today announced that Judge Robert Sweet of the United States District Court for the Southern District of New York issued a summary judgment on March 8, 2013 dismissing a class action suit against the Company, and its former...Fri, 22 Mar 2013 12:00:00 AM GMThttp://www.pharmalot.com/2013/03/tevas-cephalon-accused-of-fraud-by-whisteblower/Two years ago, the US Attorney in New York opened an investigation into Cephalon, which was since bought by Teva Pharmaceuticals, over allegations of off-label marketing of its Treanda medication for treating chronic lymphocytic leukemia. And now we learn that, in August 2010, a former Cephalon manager filed a whisteblower lawsuit against the drugmaker over alleged illegal marketing of that drug and...Thu, 21 Mar 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/03/20/sanofi-lawsuit-class-idUSL1N0CCDVS20130320A U.S. judge certified on Wednesday a class of investors who have filed a lawsuit accusing Sanofi of misleading them about the status of regulatory approval for a failed anti-obesity pill. U.S. District Judge George Daniels in Manhattan said investors in Sanofi's American depositary receipts could proceed together as a group in the litigation. Representatives for the company, formerly known as Sanofi...Thu, 21 Mar 2013 12:00:00 AM GMThttp://www.pharmalot.com/2013/03/roche-slammed-by-judge-for-recusal-request/In rather stark terms, a New Jersey state court judge recently rejected a request by attorneys for Roche who accused her of bias in long-running and sprawling litigation over the Accutane acne medication. And in her remarks, Superior Court Judge Carol Higbee maintains that she has worked hard to appear even-handed despite several instances in which actions by the Roche legal team have raised serious...Wed, 06 Mar 2013 12:00:00 AM GMThttp://legalnewsline.com/issues/big-pharma/239773-md-ag-files-suit-against-glaxosmithklineMaryland Attorney General Douglas Gansler filed a lawsuit Wednesday against GlaxoSmithKline alleging that the pharmaceutical company used misleading marketing for the prescription drugs Avandaryl, Avandamet and Avandia. GlaxoSmithKline allegedly promoted the drugs as superior to other diabetes medications even though they were not actually better at treating the disease and withheld data that showed...Fri, 22 Feb 2013 12:00:00 AM GMThttp://www.outsourcing-pharma.com/Contract-Manufacturing/Takeda-Cracks-Down-on-CMO-Plant-Suspended-After-Manufacturing-ViolationTakeda says it will help Nihon Pharmaceuticals bring manufacturing operations up to code after Japanese regulators order the CMO to halt production and recall one lot of its vitamin B1 shot.Thu, 21 Feb 2013 12:00:00 AM GMThttp://www.bizjournals.com/sanfrancisco/blog/biotech/2013/02/intermune-ipf-esbriet-shionogi.html?ana=otjInterMune Inc. will pay a Japanese drug maker a 4.25 percent royalty on European sales from this year into 2021 of its treatment for a fatal lung-scarring disease, according to a proposed settlement of a lawsuit. Importantly for Brisbane-based InterMune (NASDAQ: ITMN), it will not pay a royalty to Shionogi & Co. of Osaka, Japan, on potential U.S. sales of the drug, known as Esbriet or pirfenidone...Wed, 20 Feb 2013 12:00:00 AM GMThttp://www.bloomberg.com/news/2013-02-19/takeda-faces-first-trial-over-actos-diabetes-drug-in-l-a-.htmlTakeda Pharmaceutical Co., Asias biggest drugmaker, is facing its first trial of lawsuits alleging that its Actos diabetes drug caused cancer in some patients. Jack Cooper, a former cable splicer for Pacific Bell who took Actos for more than two years, contends officials of Takedas U.S. unit didnt properly warn consumers that Actos could cause bladder cancer. Jury selection in Coopers case is slated...Tue, 19 Feb 2013 12:00:00 AM GMThttp://www.thepharmaletter.com/file/120055/us-court-of-appeals-confirms-validity-of-astrazeneca-seroquel-xr-patent.htmlA U.S. appeals court on Thursday upheld a lower court ruling that found the formulation patent for AstraZeneca's anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan Inc and other companies seeking to sell generic versions of the medicine. Without explanation, the U.S. Court of Appeals for the Federal Circuit in a one-line order affirmed the decision issued by a New Jersey federal...Fri, 15 Feb 2013 12:00:00 AM GMThttp://www.reuters.com/article/2013/02/14/teva-costs-idUSL1N0BE0R620130214Teva Pharmaceutical Industries Ltd. (TEVA) may be on the hook for up to $2.1 billion in damages because it sold generic copies of Pfizer Inc.'s (PFE) heartburn reliever Protonix before the drug's U.S. patent exclusivity expired in 2011. The Israel-based generic-drug maker already booked a $670 million provision for the third quarter of 2012 to cover a potential Protonix loss. Now, in its 2012 annual...Thu, 14 Feb 2013 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20130211006455&newsLang=enTOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573): Sucampo Pharmaceuticals, Inc. ("Sucampo") announced that it, together with R-Tech Ueno, Ltd., Sucampo AG, and Takeda Pharmaceutical Company Limited ("Takeda") and certain affiliates of Takeda, has filed a patent infringement lawsuit against Anchen Pharmaceuticals, Inc. ("Anchen"), which had filed Abbreviated New Drug Application (ANDA) with the U...Tue, 12 Feb 2013 12:00:00 AM GMThttp://www.wpsdlocal6.com/news/ky-state-news/Kentucky-announces-55-million-medical-fraud-settlement-with-AstraZeneca-190286011.htmlKentucky will be receiving $5.5 million in settlement money from AstraZeneca Pharmaceuticals LP to resolve allegations the company marketed one of their drugs incorrectly. Attorney General Jack Conway says Astra Zeneca marketed Seroquel, an atypical antipsychotic drug, for uses not cleared by the Food and Drug Administration. I am pleased that we have reached this settlement and are recovering millions...Fri, 08 Feb 2013 12:00:00 AM GMThttp://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/american-consumers-approach-court-to-consider-recall-of-ranbaxys-generic-drug-lipitor/articleshow/18326140.cmsA group of American consumers has approached a court in the United States to consider a complete recall of Ranbaxy's blockbuster generic drug Lipitor from pharmacies and consumers. Last November, RanbaxyBSE -3.48 % had effected a limited recall of 41 lots of the drug from US pharmacies as it feared some of its drugs may be containing tiny glass particles. The consumers have sought a preliminary injunction...Mon, 04 Feb 2013 12:00:00 AM GMThttp://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/9835915/UK-families-face-compensation-fight-with-GSK-over-Avandia-drug.htmlThousands of families in the UK could be deprived of compensation for the death or harm of a relative caused by the diabetes drug Avandia, even though the British maker has agreed to pay billions of dollars to settle similar claims in the US. The licence for Avandia was revoked in Europe, in September 2010, because of evidence that it could cause heart failure and heart attacks. The drug can still...Wed, 30 Jan 2013 12:00:00 AM GMThttp://pennrecord.com/news/8857-judge-dismisses-qui-tam-action-against-astrazenecaA federal judge in the Eastern District of Pennsylvania has dismissed a whistleblower suit against AstraZeneca Pharmaceuticals that alleged the drug manufacturer entered into fraudulent agreements to sell its brand-name drugs. Pharmacist Karl Schumann, who was vice president of pharmaceutical contracting for Medco from December 1999 to January 2003, had alleged that AstraZeneca entered into sham contracts...Wed, 30 Jan 2013 12:00:00 AM GMThttp://www.pharmabiz.com/NewsDetails.aspx?aid=73294&sid=1The final hearings in the German pharma major Bayer's appeal against Indias first-ever compulsory licence issued on sorafenib tosylate (Nexavar) will begin at the Intellectual Property Appellate Board (IPAB), Chennai on January 23. According to sources, the hearing on this crucial issue is expected to conclude very soon. In its appeal, Bayer is arguing that the Patent Controller erred in the decision...Tue, 22 Jan 2013 12:00:00 AM GMThttp://www.foxbusiness.com/news/2013/01/14/supreme-court-rejects-generic-challenge-to-otsuka-abilify-patent/The U.S. Supreme Court left intact a ruling that lets Otsuka Holdings Co. (4578)s pharmaceutical unit block generic competition to its schizophrenia drug Abilify in the U.S. until April 2015. The justices today turned away an appeal by Canadian generic-drug maker Apotex Corp. The company challenged the patent for Abilifys active ingredient, contending it would have been obvious to scientists based...Tue, 15 Jan 2013 12:00:00 AM GMThttp://www.thehindubusinessline.com/companies/bristolmyers-sues-dr-reddys-for-patent-infringement-in-us/article4245274.ece?homepage=true&ref=wl_homeUS-based drug maker Bristol-Myers Squibb Company has filed patent infringement case against Dr Reddy's LaboratoriesBSE 0.00 % (DRL) over the cancer drug Ixempra. Bristol-Myers in its petition filed in the United States District Court of New Jersey alleged that the Indian drug maker has infringed the patents of its drug on three counts. According to the petition, by a letter dated November 13, 201...Fri, 28 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=282876&full=1BRIDGEWATER, N.J.</span>, <span class"xn-chron">Dec. 19, 2012</span> /PRNewswire/ -- Sanofi US announced today that it has entered into a settlement agreement with the U.S. Attorney's Office, District of <span class"xn-location">Massachusetts</span>, the United States Department of Justice and multiple states to resolve all claims arising out of an investigation into sampling of Sanofi's former viscosupplement...Thu, 20 Dec 2012 12:00:00 AM GMThttp://www.reuters.com/article/2012/12/19/us-glaxosmithkline-settlement-idUSBRE8BI14F20121219Drug giant GlaxoSmithKline (NYSE: GSK) has agreed to pay several U.S. wholesalers $150 million to settle a lawsuit in which the company was accused of delaying generic alternatives to its Flonase nasal spray. GSK confirms that is has reached an amicable resolution with the plaintiffs to bring these matters to a close," a company spokesperson told the U.K. Telegraph. "The parties agree that the settlement...Thu, 20 Dec 2012 12:00:00 AM GMThttp://www.reuters.com/article/2012/12/11/france-mediator-idUSL5E8NBGI520121211?feedType=RSS&feedName=rbssHealthcareNews&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+reuters%2FUShealthcareNews+%28News+%2F+US+%2F+Healthcare+News%29A Paris court formally placed the founder of French drugmaker Servier under investigation on Tuesday on suspicion of manslaughter for his role in the Mediator anti-diabetes drug scandal, his lawyer said. In one of France's biggest health scandals, officials blamed at least 500 deaths on the drug that was often prescribed for weight loss before being pulled from the French market in 2009, about a decade...Fri, 14 Dec 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=281662&full=1<div id"releaseBody"><p>CARLSBAD, CA--(Marketwire - December 07, 2012) - International Stem Cell Corporation (OTCQB: <a href"http://www.marketwire.com/mw/stock.jsp?TickerISCO">ISCO</a>) (<a href"http://ctt.marketwire.com/?release963084&id2366347&type1&urlhttp%3a%2f%2fwww.internationalstemcell.com%2f">www.internationalstemcell.com</a>), a biotechnology company focused on the development of...Fri, 07 Dec 2012 12:00:00 AM GMThttp://timesofindia.indiatimes.com/business/india-business/Supreme-Court-sends-Pfizer-Cipla-case-back-to-Patent-Office/articleshow/17409961.cmsIn a landmark ruling, the Supreme Court, has sent back a case involving crucial renal cancer drug, Sunitinib (sold as Sutent by Pfizer) to the patent authority, according to a lawyer involved in the case. This implies that the patent authority will re-examine the case, while the domestic company, Cipla is expected to argue against granting of the patent to Pfizer, all over again. At the same time...Thu, 29 Nov 2012 12:00:00 AM GMThttp://www.bloomberg.com/news/2012-11-27/teva-won-t-sell-gilead-generics-until-june-or-ruling.htmlTeva Pharmaceuticals agreed to delay the introduction of generic versions of two Gilead Sciences Inc. (GILD) HIV drugs until June if a judge hasnt ruled in its favor by then in a patent case brought by Gilead. U.S. District Judge Richard Sullivan in Manhattan is set to begin a non-jury trial of Gileads patent-infringement lawsuit Feb. 20. If he doesnt rule by June 1, Teva may begin to sell the drugs...Wed, 28 Nov 2012 12:00:00 AM GMThttp://www.theday.com/article/20121121/BIZ03/311219657/-1/BIZIn yet another case of insider trading to unnerve the pharmaceutical industry, federal prosecutors have cited a leading Alzheimers expert, who chaired the safety monitoring committee for the 2008 trial of the bapi drug that was developed by Wyeth and Elan, as a tipster in what is being called the most lucrative insider trading scheme ever charged. The feds say that University of Michigan neurology...Mon, 26 Nov 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/11/eisai-insurer-balks-at-paying-whistleblower-claim/For the past several years, nearly every large drugmaker has agreed to pay settlements with the US federal government over allegations of illegal promotions. Generally, these deals result from separate, but related lawsuits filed by former employees who claim they were fired in retaliation for complaining about alleged off-label marketing practices. Taken together, the growing number of settlements...Mon, 26 Nov 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/11/takeda-consultant-loses-two-whistleblower-suits/Helen Ge is now 0-for-2. Earlier this month, a federal judge tossed two different whistleblower lawsuits that the former drug safety consultant had filed against Takeda Pharmaceuticals. She alleged the drugmaker misrepresented or altered descripions of adverse events for the Uloric gout treatment and failed to report instances of bladder cancer and congestive heart failure concerning the Actos diabetes...Tue, 20 Nov 2012 12:00:00 AM GMThttp://www.philly.com/philly/business/20121116_Glaxo_pays__90_million_to_settle_states__Avandia_claims.htmlGlaxoSmithKline P.L.C. agreed to pay $90 million to settle claims by 37 states, including Pennsylvania and New Jersey, and the District of Columbia that the company illegally promoted the Avandia diabetes medicine. The settlement resolves claims by state attorneys general that the London-based Glaxo misled consumers about whether Avandia caused heart attacks and strokes in order to pump up sales. The...Fri, 16 Nov 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/11/teva-is-sued-for-not-disclosing-executive-pay/How much compensation does Teva Pharmaceuticals pay ceo Jeremy Levin and his executive team? Only their accountants and a few select insiders know for sure. Why? The drugmaker claims to adhere to Israeli law, which permits companies with dual stock exchange listings to report these salaries on a group basis, rather than disclose individual sums. However, a pair of Israeli academics, who are also...Wed, 14 Nov 2012 12:00:00 AM GMThttp://www.bloomberg.com/news/2012-11-08/astrazeneca-settles-toprol-xl-lawsuit-for-11-million.htmlAstraZeneca Plc (AZN) and affiliates will pay as much as $11 million to settle claims the company violated antitrust and consumer-protection laws by keeping generic versions of the heart drug Toprol XL off the market. Consumers and other buyers who paid for the drug from 2005 to 2012 may share in the fund by filing claim forms, available through www.ToprolSettlement.com, according to a statement today...Fri, 09 Nov 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&newsId=20121012005775&newsLang=enSOUTH SAN FRANCISCO, Calif. & MLNDAL, Sweden--(BUSINESS WIRE)--Cellectricon AB and Fluxion Biosciences today announced that they have settled the patent infringement litigation that Cellectricon commenced against Fluxion in 2009. Cellectricon and Fluxion have agreed to file a stipulation of dismissal with the United States District Court for the Northern District of California for all claims brought...Mon, 15 Oct 2012 12:00:00 AM GMThttp://www.pharmpro.com/news/2012/10/pharmaceutical-companies-GSK-Announces-Initiatives/GlaxoSmithKline, criticized in the past for keeping important information about its medicines to itself, is to lift the lid on more of its drug secrets. Three months after GSK was fined $3 billion for fraud in the United States, where prosecutors accused it of concealing safety issues, chief executive Andrew Witty said on Thursday detailed data from its clinical trials would be made available to other...Fri, 12 Oct 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=273793&full=1LONDON, UK (GlobalData), 21 September 2012 - An application filed by Novartis in India for the patent protection of its tyrosine kinase inhibitor, Glivec (imatinib mesylate), has been in legal oblivion for some time. Glivec, which received US FDA approval in May 2001, is indicated for the treatment of multiple cancer types, including newly diagnosed adult and pediatric patients with Philadelphia chromosome...Fri, 21 Sep 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/09/bayer-loses-nexavar-compulsory-license-battle/Generic drug makers and disadvantaged patients are the winners here, because Indias Intellectual Property Appellate Board rejected a petition from Bayer on Friday that sought a stay on an order of Controller of Patents. What this now means is that the Hyderabad-based Natco Pharma Limited, a generic drug company, can act on its compulsory license for Bayers kidney and liver cancer drug Nexavar. Natco...Tue, 18 Sep 2012 12:00:00 AM GMThttp://www.thehindubusinessline.com/companies/article3888106.eceThe Supreme Court today asked Swiss pharma giant Novartis AG whether it should not sell its anti-cancer drug for Rs 5 each to benefit common man. A Bench of Justices Aftab Alam and Ranajan Prakash Desai posed the query to Novartis AG while hearing its plea seeking affirmation of the exclusivity of its blood cancer drug Glivec and its right to get it patented in India. Why dont you sell it for Rs...Wed, 12 Sep 2012 12:00:00 AM GMThttp://www.moneycontrol.com/news/buzzing-stocks/cipla-hits-new-52-week-highpatent-case-win_755701.htmlAn Indian court has ruled in favour of local drugmaker Cipla in a patent infringement case filed by Switzerland's Roche Holding AG over Cipla's cancer drug Erlocip, a senior executive of the Indian company said. The Delhi High Court made the ruling a week before India's Supreme Court is due to begin hearing a patent plea by another Swiss drugmaker, Novartis AG, over its cancer drug Glivec. That case...Mon, 10 Sep 2012 12:00:00 AM GMThttp://newsandinsight.thomsonreuters.com/New_York/News/2012/09_-_September/3rd_Circuit_pay-for-delay_ruling_sparks_Nexium_antitrust_suits/The brand-name and generic pharmaceutical companies of the world had better hope that the U.S. Supreme Court grants Merck's petition for certiorari in the K-Dur pay-for-delay case (and ultimately reverses the 3rd Circuit Court of Appeals). If not, I have a feeling more of pharma manufacturers are going to find themselves the target of class actions like the ones AstraZeneca is now facing in New Jersey...Fri, 07 Sep 2012 12:00:00 AM GMThttp://www.bizjournals.com/boston/blog/mass_roundup/2012/08/sanofi-insider-trading.html?ana=otjrssFederal securities regulators charged eight people in Georgia with insider trading on Tuesday, saying they bought stock in a company ahead of a merger announcement after one of them learned about a pending deal. The Securities and Exchange Commission said that Thomas D. Melvin Jr., an accountant from Griffin, Ga., learned from a client that the drug giant Sanofi-Aventis was planning to buy Chattem...Wed, 29 Aug 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/08/astrazeneca-pays-26m-to-settle-seroquel-suit/For the past year, AstraZeneca was aggressively pursuing a strategy to challenge a state lawsuit that relied on the use of private law firms and contingency fee arrangement. Several drugmakers, in fact, adopted this approach in response to state lawsuits that charged various drugs were marketed illegally and state programs and taxpayers overpaid for the medicines. Drugmakers believe the outside law...Mon, 27 Aug 2012 12:00:00 AM GMThttp://www.businessweek.com/news/2012-08-24/lilly-wins-appeal-upholding-patent-for-alimta-cancer-drugEli Lilly & Co. (LLY) won a U.S. appeals court ruling that upholds the validity of a patent for the lung- cancer drug Alimta and blocks generic competition through 2017. The U.S. Court of Appeals for the Federal Circuit today rejected arguments by Teva Pharmaceutical Industries Ltd. (TEVA) that the patent was invalid. It affirmed a lower court ruling. The decision was posted on the courts website...Mon, 27 Aug 2012 12:00:00 AM GMThttp://www.outsourcing-pharma.com/Commercial-Services/United-Drug-asks-US-Courts-to-throw-out-Catalent-suit-about-packaging-bizIRISH health services firm United Drug yesterday filed its motion to dismiss legal action brought against it in the US by a company controlled by investment giant Blackstone. United Drug and its US subsidiary Sharp Corporation had been ordered by the judge assigned to the case in New York, Barbara Jones, to file their motion yesterday. The two companies were sued last month by a company called Catalent...Thu, 23 Aug 2012 12:00:00 AM GMThttp://latimesblogs.latimes.com/world_now/2012/08/indian-court-case-novartis-generic-medicines-drugs-patent.htmlThe Supreme Court will hear final arguments from September 11 in a key patent dispute between Swiss drugmaker Novartis and India's patent office, a case that could curb India's global position as a supplier of cut-price generic medicines. The hearing, which is expected to last for at least two months, had been scheduled to being on Wednesday. Novartis appealed to the Supreme Court after its cancer...Wed, 22 Aug 2012 12:00:00 AM GMThttp://rapsinews.com/judicial_news/20120820/264342606.htmlThe Moscow Commercial Court will review on September 24 a Johnson & Johnson (J&J) subsidiary's lawsuit against the antitrust watchdogs order to include the company on its monopolist list, the court told the Russian Legal Information Agency (RAPSI/rapsinews.com). Under the watchdog's April 16 order, Cilag GmbH International was placed on the list of companies having an over 50 percent market share...Tue, 21 Aug 2012 12:00:00 AM GMThttp://www.reuters.com/article/2012/08/20/us-novartis-india-idUSBRE87I09M20120820India's highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector and potentially curb its global role as a supplier of cut-price generic medicines. The Supreme Court hearing pits Swiss drugmaker Novartis AG against India's patent office, which has refused to grant a patent on the company's cancer...Mon, 20 Aug 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/08/fresenius-threatens-to-sue-doc-over-study/Fresenius Kabi is threatening legal action against a Danish professor after he and several colleagues recently published a paper in The New England Journal of Medicine that concluded its hydroxyethyl starch treatment for sepsis may cause kidney failure and hemorrhages that may lead to patient death, ScienceNordic reports (here is the abstract). At the time the study was published in June, Anders Perner...Mon, 13 Aug 2012 12:00:00 AM GMThttp://www.menafn.com/menafn/dfab9d91-7fa8-4817-ae16-c67bb397d958/SEC-opens-Teva-bribery-probe?src=mainIsrael's Teva Pharmaceutical Industries , the world's biggest generic-drug maker, is being investigated by the U.S. securities regulator over the company's compliance with a U.S. law that prohibits bribery of foreign officials. In a filing with the U.S. Securities and Exchange Commission last week, Teva said it had received a subpoena dated July 9 to produce documents in connection with its business...Mon, 06 Aug 2012 12:00:00 AM GMThttp://timesofindia.indiatimes.com/business/india-business/Natco-in-patent-war-with-BMS/articleshow/15301657.cmsNatco, which successfully managed to reduce prices of Bayer's cancer drug Nexavar by 97% through the country's first compulsory licence recently, is headed for another major confrontation. This time the tussle is with drug MNC Bristol-Myers Squibb (BMS) over Dasatinib, a crucial medicine used in chronic myeloid leukemia, and is expected to set yet another precedent for the Indian generics industry...Thu, 02 Aug 2012 12:00:00 AM GMThttp://www.businessweek.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-dot-6-millionBayer AG (BAYRY) (BAYRY) said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots in women have increased to more than $402 million. Bayer, based in Leverkusen, Germany, has resolved almost 1,900 cases (BAYRY) in which its alleged that its Yasmin and Yaz contraceptives caused clots that can lead to heart attacks and strokes, the company said today...Wed, 01 Aug 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/07/teva-sues-genzyme-for-poaching-employees/In April 2012, Kevin Middleton left his position as head of sales for the Teva Pharamceutical specialty sales force, where he oversaw promotion for such neuroscience meds as the Copaxone multiple sclerosis treatment. As part of his departure, he signed a separation agreement that prevented him from soliciting other Teva employees for up to one year. But within two months of leaving Teva, he went to...Tue, 31 Jul 2012 12:00:00 AM GMThttp://www.thepharmaletter.com/file/115314/eu-commission-focus-now-on-servier-and-others-re-perindopril-antitrust-issues.htmlEU antitrust regulators charged French drugmaker Servier, Israel's Teva and four other firms on Monday with blocking the entry of a cheaper generic medicine to market as part of a crackdown on a key business practice in the industry. The European Commission had flagged the move last week after charging nine drug companies including Germany's Merck and Danish peer Lundbeck for a similar offence related...Tue, 31 Jul 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20120731005977&newsLang=enGTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolifes subsidiary in the U.S.A., Vitrolife, Inc, has together with Southwest Transplant Alliance and University of Texas been sued for compensation by relatives to a patient who deceased after a lung transplantation in 2010. Tue, 31 Jul 2012 12:00:00 AM GMThttp://www.yorkshirepost.co.uk/business/business-news/glaxo-admits-mistakes-over-us-guilt-1-4774408Drugs giant GlaxoSmithKline yesterday admitted to unacceptable mistakes in the United States following its recent 1.9bn fine to settle the largest healthcare fraud in American history. Announcing interim results, chief executive Sir Andrew Witty said he was very sorry for the groups actions after Glaxo pleaded guilty this month to mis-promoting two medicines by seeking to persuade doctors to...Fri, 27 Jul 2012 12:00:00 AM GMThttp://www.bloomberg.com/news/2012-07-25/lundbeck-gets-eu-antitrust-complaint-on-citalopram-deals.htmlBrussels, 25 July 2012 -- The European Commission has informed the Danish pharmaceutical company Lundbeck of its objections regarding agreements concluded with four generic competitors concerning citalopram, a blockbuster antidepressant. The Commission is of the preliminary view that the agreements aimed at preventing the market entry of cheaper generic medicines, in violation of EU antitrust rules...Wed, 25 Jul 2012 12:00:00 AM GMThttp://www.pharmalot.com/2012/07/pfizer-wins-price-fixing-case-in-indonesia/Nearly two years after Pfizer and Dexa Medica were fined for participating in a price-fixing scheme for anti-hypertensive tables, the Indonesian Supreme Court has upheld a lower court ruling that overturned the penalties. The case originated with the Business Competition Supervisory Agency, or KPPU, which had determined the price of Norvasc was 14.6 times more expensive than the average international...Thu, 19 Jul 2012 12:00:00 AM GMThttp://www.courthousenews.com/2012/07/10/48235.htmA federal judge shot down the latest attempt by AstraZeneca Pharmaceuticals to block Food and Drug Administration approval of the generic versions of its antipsychotic drug Seroquel. The drug is considered atypical because it results in fewer undesirable side effects such as tics and tremors, compared to previous antipsychotics. Schizophrenia and bipolar disorder are among the conditions the drug is...Wed, 11 Jul 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.b30484b92e958b11adda3242e6908a0c/index.jsp?ndmViewId=news_view&newsId=20120711005685&newsLang=enJERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced that the United Kingdom High Court of Justice issued a decision in favor of Teva in a patent litigation proceeding against Generics (UK) Limited, a subsidiary of Mylan Laboratories Inc., on July 11, 2012. Generics (UK) Limited commenced the proceeding in the UK to seek the revocation of European Patent (UK) 762...Wed, 11 Jul 2012 12:00:00 AM GMT